Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) was down 1.6% during mid-day trading on Thursday . The stock traded as low as €21.12 ($21.99) and last traded at €21.30 ($22.19). Approximately 2,843,595 shares traded hands during mid-day trading, The stock had previously closed at €21.64 ($22.54).
Bayer Aktiengesellschaft Price Performance
The company has a market cap of $22.26 billion, a P/E ratio of -25.30, a P/E/G ratio of 36.39 and a beta of 0.97. The stock's 50-day moving average is €20.38 and its two-hundred day moving average is €23.65.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Stories
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
